Washington, D.C. · Nonprofit
DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform
DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform (Washington, D.C.) receives grants from 4 organizations whose IRS filings report $86,307 to it, the largest being NETWORK FOR GOOD ($56,302). 2 of them have funded it in more than one year, and 65% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2025
- $78k
- Funders on record
- 4
- Grants received
- $86k
- Net assets
- $53k
What DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform does
Mission
Doctors for Drug Policy Reform (D4DPR) is organized and operated exclusively for charitable and educational purposes to advance public health through evidence-based drug policy reform. The organization educates policymakers, health professionals, and the public on the health effects of drug use and the consequences of drug laws; develops and disseminates scientific, clinical, and policy analyses; and promotes approaches that reduce harm, improve access to treatment, and decrease stigma associated with substance use disorders. D4DPR engages in nonpartisan research, education, and public health advocacy consistent with its mission to improve health outcomes and inform rational, science-driven drug policies
As stated on its FY2025 Form 990-EZ.
Programs
Expansion of Mission and Public Health Scope During the reporting period, D4DPR continued its transition from a cannabis-focused organization to a broader public health-oriented organization addressing drug policy across all illegal drugs. This expansion enabled the organization to engage a wider range of physicians, scientists, and health professionals; address emerging and complex drug-related public health issues; and contribute to national and international discussions on evidence-based, health-centered drug policy. This work supports the organization's charitable purpose by reducing stigma, improving public understanding, and promoting policies that enhance health outcomes.
$226 spent1% of program spendingAdvancement of Evidence-Based Regulatory Standards D4DPR's work in developing standardized cannabis labeling and warnings continued to influence state-level regulatory frameworks. The International Intoxication Cannabinoid Product Symbol (IICPS), developed with D4DPR involvement, has been adopted in multiple states and is under consideration in additional jurisdictions. Standardized warning language developed by D4DPR has also been adopted at the state level. These efforts contribute to improved consumer awareness, product safety, and consistency in public health messaging.
$226 spent1% of program spendingEducation and Dissemination of Scientific and Policy Information D4DPR provided education to healthcare professionals, policymakers, and the public through webinars, written publications, and media engagement. Educational topics included hemp-derived cannabinoids, international drug policy, psychedelics, overdose prevention strategies, and treatment for substance use disorders. The organization produced and disseminated position papers and policy analyses addressing cannabis scheduling, overdose prevention centers, and related issues. Outreach activities included webinars, op-eds, letters to the editor, and media appearances, expanding access to evidence-based information and supporting informed decision-making.
$2,495 spent13% of program spendingDevelopment of the Health Advocacy Toolkit With grant support, D4DPR developed a comprehensive Health Advocacy Toolkit designed to train healthcare professionals in effective, evidence-based public health advocacy. The toolkit includes policy briefs, fact sheets, and instructional modules on engaging with legislative and regulatory processes, preparing written and oral testimony, and communicating scientific information to policymakers. This initiative increases the capacity of clinicians to participate in public health policy discussions and promotes the dissemination of accurate, science-based information.
$15,857 spent83% of program spendingD4DPR launched Physicians for Opioid Settlement Equity (POSE), an initiative aimed at promoting the equitable and evidence-based allocation of opioid settlement funds. This initiative is focused on New York and New Jersey. POSE engages physicians and other healthcare professionals to educate policymakers and the public on effective uses of settlement funds, including treatment access, harm reduction services, and prevention strategies. This initiative advances public health by supporting the allocation of resources toward interventions with demonstrated effectiveness in reducing overdose and improving outcomes for individuals with substance use disorders.
$113 spent1% of program spendingCoalition Participation and Collaborative Public Health Efforts D4DPR actively participated in national and state-level coalitions focused on drug policy reform and public health. Through these collaborations, the organization contributed medical and scientific expertise to policy discussions, educational initiatives, and public communications. Participation in coalitions enhances the organization's ability to disseminate evidence-based information, amplify its impact, and support coordinated approaches to improving drug policy and health outcomes.
$266 spent1% of program spending
The 6 programs described on its FY2025 Form 990-EZ. Program spending in total: $19,183.
The organization over time
Each line starts at 100 in 2021, so what you read is the shape rather than the size: 150 means half as much again as 2021, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2024 to 2025, from $16k to $65k (+307%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
100% of DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform’s revenue is contributions — more reliant on donations than three-quarters of its peers (97% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 5 reported years ran a deficit.
Who funds it, year by year
2017 → 2023: the base held at 1 funder, grant income rose $10k → $17k.
2 of 4 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 65% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform leans on a few funders — its largest provides 65% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
83% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform.
Largest funder’s share by year: 2017 100% · 2018 100% · 2021 100% · 2022 100% · 2023 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
65% of DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $30k that is directly attributable, 100% of it comes from funders outside Washington, D.C., across 2 states.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $56k arriving through sponsors registered in 2 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform runs a healthier operating margin than three-quarters of the 2,277 public benefit nonprofits its size.
this organization peer median middle 50% of peers· 2,277 public benefit nonprofits under $100k, FY2025
Organizations like DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Washington, D.C.
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Public support
80%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Screen this organization
A dated, signed PDF of the compliance screen for DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform?
- DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform (Washington, D.C.) receives grants from 4 organizations whose IRS filings report $86,307 to it, the largest being NETWORK FOR GOOD ($56,302). 2 of them have funded it in more than one year, and 65% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform have?
- IRS filings report 4 organizations giving $86,307 in grants to DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform, 2 of which have funded it in more than one year.
- Who is the largest funder of DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform?
- NETWORK FOR GOOD is the largest funder on record, with $56,302 in grants. The full list of funders is on this page.
- How can an organization like DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Washington, D.C.. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds DOCTORS FOR CANNABIS REGULATION dba Doctors for Drug Policy Reform →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2021–2025), and the filings of 4 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing